Xilio Therapeutics, Inc. Payments for Restructuring
Xilio Therapeutics, Inc. (XLO) reported Payments for Restructuring of $922.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2024-11-07
- Xilio Therapeutics, Inc. payments for restructuring for the quarter ending 2024-09-30 was $236.00K.
- Xilio Therapeutics, Inc. payments for restructuring for the quarter ending 2024-06-30 was $686.00K.
- Xilio Therapeutics, Inc. payments for restructuring for the quarter ending 2024-03-31 was $0.00.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month |
|---|---|---|---|
| 2024-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $922.00K derived: sum of 2 quarters · filed 2024-11-07 | $922.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $686.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |